Article
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
Molecular diagnosis & therapy - 1 Jan 2007
Bremer Troy, Diamond Cornelius, McKinney Rebecca, Shehktman Tatyana, Barrett Thomas B, Herold Chris, Kelsoe John R
Abstract excerpt
BACKGROUND: Based on results from randomized, controlled clinical trials, lithium monotherapy or lithium with the addition of an antipsychotic remains a first-line treatment option for both acute and long-term mood stabilization in bipolar mania. However, response to lithium is poor in bipolar pa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
